1. Home
  2. RDW vs PCRX Comparison

RDW vs PCRX Comparison

Compare RDW & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$8.22

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.63

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
PCRX
Founded
2020
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
RDW
PCRX
Price
$8.22
$25.63
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$12.67
$32.86
AVG Volume (30 Days)
10.8M
916.4K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$296,147,000.00
$716,791,000.00
Revenue This Year
$11.62
$6.24
Revenue Next Year
$42.89
$9.53
P/E Ratio
N/A
$55.21
Revenue Growth
N/A
3.14
52 Week Low
$4.87
$18.17
52 Week High
$26.66
$27.64

Technical Indicators

Market Signals
Indicator
RDW
PCRX
Relative Strength Index (RSI) 63.65 56.92
Support Level $6.32 $25.48
Resistance Level $8.20 $27.16
Average True Range (ATR) 0.79 1.00
MACD 0.24 0.03
Stochastic Oscillator 77.47 56.64

Price Performance

Historical Comparison
RDW
PCRX

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: